Scholarlink

Background <p>Uremic pruritus (UP) is a common issue for individuals with chronic kidney disease undergoing hemodialysis (HD), mainly due to a lack of essential fatty acids. These fatty acids and their derivatives supplementation had shown positive effects, especially in promoting anti-inflammatory omega-3 fatty acids. This study aimed to evaluate the effect of omega-3 fatty acids, as opposed to gabapentin, on pruritus in HD patients.</p> Methods <p>Fifty prevalent HD patients were recruited from the HD Department of Ain-Shams University Hospital for a three-and-a-half-month randomized controlled crossover trial. Participants were randomized into two groups:<UnorderedList Mark="Bullet"> <ItemContent> <p>Group A consisted of 25 patients who received omega-3 in addition to standard therapy, with calcium and erythropoietin stimulation for a 4-week treatment phase, followed by 5&#xa0;weeks of washout receiving standard treatment alone. Gabapentin was subsequently administered.</p> </ItemContent> <ItemContent> <p>Group B consisted of 25 patients who received gabapentin in addition to standard therapy, which included calcium and an erythropoietin stimulant. The patients received 4&#xa0;weeks of treatment, followed by a 6-week washout with only standard care. Omega-3 was given after the washout period.</p> </ItemContent> </UnorderedList></p> Results <p>Prostaglandin E2 (PGE2) levels were significantly reduced among patients treated with omega-3 compared to gabapentin. The 5-D itch scale was significantly reduced among all patients after treatment with omega-3 or gabapentin, with no significant difference.</p> Conclusion <p>Omega-3 fatty acids are similarly effective as gabapentin in treating uremic pruritus. Omega-3 fatty acids show promise as an effective medication for treating pruritus in people with uremia.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Omega-3 fatty acids versus gabapentin in uremic pruritus in hemodialysis patients: randomized controlled, crossover clinical trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月22日

查看全文
  • Nahla Mohamed Teama,
  • Sahar Mahmoud Shawky,
  • Mona Abdel-Halim Ibrahim,
  • Sara Mohammed Khalifa,
  • Ashraf Hassan El-Mobdy

摘要

Background

Uremic pruritus (UP) is a common issue for individuals with chronic kidney disease undergoing hemodialysis (HD), mainly due to a lack of essential fatty acids. These fatty acids and their derivatives supplementation had shown positive effects, especially in promoting anti-inflammatory omega-3 fatty acids. This study aimed to evaluate the effect of omega-3 fatty acids, as opposed to gabapentin, on pruritus in HD patients.

Methods

Fifty prevalent HD patients were recruited from the HD Department of Ain-Shams University Hospital for a three-and-a-half-month randomized controlled crossover trial. Participants were randomized into two groups:

Group A consisted of 25 patients who received omega-3 in addition to standard therapy, with calcium and erythropoietin stimulation for a 4-week treatment phase, followed by 5 weeks of washout receiving standard treatment alone. Gabapentin was subsequently administered.

Group B consisted of 25 patients who received gabapentin in addition to standard therapy, which included calcium and an erythropoietin stimulant. The patients received 4 weeks of treatment, followed by a 6-week washout with only standard care. Omega-3 was given after the washout period.

Results

Prostaglandin E2 (PGE2) levels were significantly reduced among patients treated with omega-3 compared to gabapentin. The 5-D itch scale was significantly reduced among all patients after treatment with omega-3 or gabapentin, with no significant difference.

Conclusion

Omega-3 fatty acids are similarly effective as gabapentin in treating uremic pruritus. Omega-3 fatty acids show promise as an effective medication for treating pruritus in people with uremia.